RCKT
Rocket Pharmaceuticals, Inc. · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website rocketpharma.com
- Employees(FY) 240
- ISIN US77313F1066
Performance
-3.04%
1W
-6.72%
1M
-24.63%
3M
+5.95%
6M
-24.52%
YTD
+4.92%
1Y
Profile
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells or promotes the production of faulty blood cells; leukocyte adhesion deficiency-I, a genetic disorder that causes the immune system to malfunction; and pyruvate kinase deficiency, a rare red blood cell autosomal recessive disorder that results in chronic non-spherocytic hemolytic anemia. The company also has a clinical stage in vivo adeno-associated virus program for Danon disease, a multi-organ lysosomal-associated disorder leading to early death due to heart failure. It has license agreements with Fred Hutchinson Cancer Research Center; Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, Centro de Investigacion Biomedica En Red, and Fundacion Instituto de investigacion Sanitaria Fundacion Jimenez Diaz; UCL Business PLC; The Regents of the University of California; and REGENXBIO, Inc. The company is headquartered in Cranbury, New Jersey.
Investment Analysis Report: RCKT
Overview
In this investment analysis report, we will delve into the financial statements of RCKT, a company operating in the Health Technology sector within the Biotechnology industry. We will analyze the company's financial health, earnings and revenue growth, profitability, operating margin, operating cash flow...
Technical Analysis of RCKT 2024-05-10
Overview:
In analyzing the technical indicators for RCKT over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key aspects, we aim to offer valuable insights and predictions for potential invest...
Recent News & Updates
- 2024-05-10 06:00
- 2024-05-09 18:00
- 2024-05-06 23:26
- 2024-05-06 16:01
- 2024-05-06 09:55
- 2024-05-06 04:01
- 2024-04-30 00:00
- 2024-04-23 23:33
- 2024-04-23 19:39
Should You Hold Immunovant (IMVT)?(Insidermonkey)
- 2024-04-02 23:32
- 2024-04-02 06:00
- 2024-04-01 18:00
- 2024-03-26 23:30
- 2024-03-26 16:01
- 2024-03-26 04:01
- 2024-02-26 23:20
- 2024-02-26 16:01
- 2024-02-26 03:01
- 2024-02-13 07:00
- 2024-02-12 18:00
- 2024-01-21 14:39
- 2024-01-03 22:55
- 2024-01-03 03:01
- 2024-01-02 16:01
- 2023-12-12 07:00
- 2023-12-11 18:00
- 2023-11-23 12:16
Billionaire Lee Ainslie’s Top 10 Stock Picks(Insider Monkey)
- 2023-11-15 11:17
- 2023-11-09 09:55
- 2023-11-06 16:15
Rocket Pharmaceuticals: Q3 Earnings Snapshot(Associated Press Finance)
Page 1 of 5
previousnext